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The balance between alternatively activated macro-
phages (AAMs)/M2 cells and classically activatedmacro-
phages (M1 cells) is largely dependent on the effects of
IL-4 and interferon (IFN)-, respectively. Although
AAM/M2 cells can suppress inflammation and repair
damaged tissue, M1 cells produce an array of pro-in-
flammatory molecules. Macrophage effector functions
are critical for host protection against many infectious
diseases, but it remains unknownwhether lethal immu-
nopathological characteristics, caused by Schistosoma
mansoni infection in IL-4 receptor –deficient mice (IL-
4R/), results from the absence of M2 cells or in-
creased numbers of M1 cells. In this study, we generated
mice that completely lack IL-4R signaling in the con-
text of a macrophage-specific loss of IFN- responsive-
ness (MIIG IL-4R/). Contrary towhat we expected,
acute schistosomiasis resulted in greater liver injury
andmortality in MIIG IL-4R/mice compared with
IL-4R/ mice. Greater tissue injury in MIIG  IL-
4R/micewas likely because of a lack of indoleamine
2,3 dioxygenase (IDO), a critical regulator of immuno-
suppression. Indeed, MIIG  IL-4R/ failed to up-
regulate IDO expression, and IL-4R/ mice treated
with an IDO antagonist underwent greater liver damage
and mortality compared with mock-treated IL-4R/
mice. Thus, we propose that, in the absence of AAM/M2
cells, IFN-–induced M1 cells suppress tissue-damaging
inflammation during acute schistosomiasis through an
IDO-dependent mechanism. (Am J Pathol 2012, 180:
2001–2008; DOI: 10.1016/j.ajpath.2012.01.013)
Worm ova released from adult-stage Schistosoma para-
sites cause granulomatous inflammation within any organwhere the eggs become lodged.1 The hepatic and intes-
tinal inflammation caused by Schistosoma mansoni eggs
can result in substantial organ injury within the host, par-
ticularly in the absence of a counterinflammatory host
response. For example, acute schistosomiasis is lethal in
IL-4–deficient mice because of excessive liver injury and
intestinal hemorrhage.2 IL-4 limits excessive tissue injury
caused by worm ova through mechanisms that are
largely dependent on CD4 T-helper (TH) 2 cells and
alternatively activated macrophages (AAMs)/M2 cells.3–5
During acute schistosomiasis, mice that specifically lack
IL-4 receptor  (IL-4R)–expressing macrophages or
mice that lack AAM/M2-associated genes develop ex-
cessive intestinal immunopathological characteristics
that are driven by type 1 cytokine production.3 Further-
more, AAM/M2 cells have suppressed IL-12/23p40 re-
lease, which, in turn, suppresses the infection-induced
expansion of TH1 and TH17 cells that drives mortality
during murine schistosomiasis.6–8
It is unclear whether host survival during schistosomi-
asis is dependent on a relative increase of AAM/M2 cells
or a decrease of M1 cells at the nidus of inflammation
caused by the worm ovum. Compared with AAM/M2
cells, interferon (IFN)-–dependent M1 cells produce
high amounts of pro-inflammatory mediators, such as
inducible nitric oxide synthetase-2, tumor necrosis factor,
and IL-12/23p40, that serve essential roles in host de-
fense against microbial pathogens.9 However, these pro-
inflammatory molecules can also cause significant collat-
eral tissue damage within the host.9,10 Specifically, IFN-
promotes severe hepatosplenic schistosomiasis,11 and
increased nitric oxide synthetase-2 and IL-12/23p40 pro-
duction contributes to severe immunopathological char-
Supported by grants R01HL091769 (M.B.J.) and R01 GM 083204 and
R01 AI 095289 (D.R.H.) from the NIH.
Accepted for publication January 9, 2012.
Current address of D.R.H., University of San Francisco, San Francisco,
California.
Address reprint requests to De’Broski R. Herbert, Ph.D., Division of
Experimental Medicine, University of California San Francisco, School of
Medicine, 1001 Potrero Ave, San Francisco, CA 94110. E-mail:
debroski.herbert@cchmc.org.
2001
2002 Rani et al
AJP May 2012, Vol. 180, No. 5acteristics in S. mansoni–infected mice lacking IL-4 or
arginase I.2,8,12 Because the increased production of
type 1–associated inflammation often occurs in the ab-
sence of a strong type 2 response, it has been particu-
larly difficult to discern the host-protective effects of
AAM/M2 cells versus the potentially deleterious role(s) of
M1 cells in the S. mansoni model system.
To address the roles of AAM/M2 and M1 cells in vivo,
we bred mice that lack IL-4/IL-13 responsiveness in all
cells (IL-4R/) with mice that lack macrophage-spe-
cific IFN- responsiveness (MIIG).13 This resulted in the
generation of novel mice that were unable to generate
AAM/M2 or M1 cells (MIIG  IL-4R/). Unexpectedly,
acute schistosomiasis in these animals was more severe
compared with IL-4R/ mice, as determined by in-
creased weight loss and mortality. This phenotype was
not attributed to differences in cytokine production. In-
stead, MIIG  IL-4R/ mice failed to up-regulate in-
doleamine 2,3 dioxygenase (IDO), an IFN-–induced
gene that is highly immunosuppressive.14 Indeed,
treatment of S. mansoni–infected IL-4R/ mice with
the IDO antagonist 1-methyltryptophan (1-MT) caused
significantly worse cachexia and multiorgan injury
compared with mock-treated IL-4R/ mice. These
data suggest that both M1 and AAM/M2 cells have
protective roles during schistosomiasis and that the
protective effects of M1 cells are likely to be IDO de-
pendent.
Materials and Methods
Mice and the S. mansoni Model
The MIIG-transgenic mice that use the CD68-IVS1 pro-
moter to drive an IFN-–dominant negative receptor have
been previously described.13 These mice were bred with
IL-4R/ mice on a C57BL/6 background and were
provided by Frank Bromabacher at the University of
Cape Town, Cape Town, South Africa. Biomphalaria
glabrata snails harboring S. mansoni cercariae were pro-
vided by the National Institute of Allergy and Infectious
Diseases Schistosomiasis Resource Center at the Bio-
medical Research Institute (Rockville, MD), through Na-
tional Institute of Allergy and Infectious Diseases contract
N0-AI-30026. All infections were performed at Cincinnati
Children’s Hospital Medical Center, and procedures
were approved by the Institutional Animal Care and Use
Committee. Mice were anesthetized and percutaneously
infected with 50 to 70 S. mansoni cercariae, as previously
described.15
Serum Analysis
Aspartate transaminase (AST) serum levels were mea-
sured by a commercially available assay from Teco Di-
agnostics (Anaheim, CA). The serum lipopolysaccharide
(LPS) concentration was measured using a commercially
available limulus amebocyte lysate kit (BioWhittaker, Lan-
caster, MA), as previously described.8ELISA
Single-cell suspensions were prepared from mesen-
teric lymph nodes at 7 weeks after infection and stim-
ulated with S. mansoni–soluble egg antigen (SEA) at 10
g/mL or left untreated. Supernatants were harvested
72 hours later, and IFN-, IL-5, IL-17A, and IL-12/
23p40 levels were quantified by enzyme-linked immu-
nosorbent assay (ELISA) (eBioscience, San Diego,
CA). Nitrite levels in supernatant were determined us-
ing a Griess reaction kit (Promega, Madison, WI).
Real-Time PCR
Tissues were homogenized in TRIzol (Molecular Re-
search Center, Cincinnati, OH) and RNA isolated using
standard techniques. RNA was DNase I treated and
cDNA prepared using SuperScript II Reverse Transcrip-
tase (Invitrogen, Carlsbad, CA). A real-time PCR was
performed on a Gene Amp 7500 instrument (PE Biosys-
tems, Foster City, CA) with the SYBR Green detection
reagent (Clonetech, Mountain View, CA). The CT values
for genes evaluated were determined and expressed
using the 1/CT method. Primer sequences used were as
follows: vimentin, 5=-GTGCGCCAGCAGTATGAAAG-3=
(forward) and 5=-GCATCGTTGTTCCGGGTTGG-3= (re-
verse); IDO-1, 5=-GGATGCGTGACTTTGTGGAC-3= (for-
ward) and 5=-TTCTTTGCCAGCCTCGTGT-3= (reverse);
IDO-2, 5=-CTGGTGCTGACAAACTGGA-3= (forward) and
5=-CTGACTGTGTTGCCGAATG-3= (reverse); IL-10, 5=-AA-
GGGTTACTTGGGTTGCCA-3= (forward) and 5=-TCACTC-
TTCACCTGCTCCAC-3= (reverse); and transforming growth
factor (TGF)-1, 5=-CCGCAACAACGCCATCTATG-3= (for-
ward) and 5=-AGCCCTGTATTCCGTCTCCT-3= (reverse).
1-MT Treatment
1-MT (Sigma-Aldrich, St. Louis, MO) was administered
in the drinking water of mice at 2 mg/mL with the
addition of sweetener (NutraSweet, Chicago, IL).16
Mock treatment was drinking water with sweetener.
Treated drinking water was changed every 4 to 5 days
during treatment.
Histological Features and Granuloma
Measurement
Liver samples were formalin fixed for 24 hours, pro-
cessed, embedded in paraffin, cut into sections (5 m
thick), and provided on coded slides by the Cincinnati
Children’s Hospital Medical Center morphological fea-
tures core facility. H&E staining was used to visualize
individual liver granuloma areas on coded slides. Gran-
uloma areas were measured on coded slides; only gran-
ulomas that possessed a central egg were evaluated.
Quantitation of area was performed using an SPOT Diag-
nostics imaging system and Simple PCI C-Imaging sys-
tems software version 4.0 (Cranberry Township, PA) for
granuloma area measurement.
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To determine statistical significance between two groups,
a one-tailed Student’s t-test was used. For multiple
groups, statistical significance was determined by anal-
ysis of variance for multiple groups, followed by Bonfer-
roni’s post hoc test. All tests were performed using Prism
Graph Pad software version 5.0 (La Jolla, CA).
Results
Generation of Transgenic Mice that Specifically
Lack IL-4/IL-13 Signaling and IFN-
Responsiveness in Macrophages
To dissect the biological roles of M1 cells versus AAM/M2
0 10 20 30 40
NO2- (µM)
WT
MIIG X IL
A
R3
R4
R2
CD
11
b
F4/80
101100 1
Ce
ll n
u
m
be
r
IL-4Rα-/-
R2
R3
CD
11
b 
Ly6C/G 
101100
Ce
ll n
u
m
be
rR4
Med
LPS
LPS
IFN-γ
B
C
*
*cells in vivo, we generated a novel mouse line from anintercross between IL-4R/ mice (a strain that lacks
IL-4 and IL-13 responsiveness on all cells) and MIIG-
transgenic mice (a strain that expresses a dominant-
negative IFN- receptor specifically in macrophages).13
These mice (designated MIIG  IL-4R/) possess
macrophages that are incapable of signaling in response
to IFN-, IL-4, or IL-13.
To ensure functional nonresponsiveness, bone mar-
row–derived macrophages were generated from wild-
type (WT), IL-4R/, and MIIG  IL-4R/ strains and
evaluated for nitrite production after exposure to bacterial
endotoxin (LPS) or a combination of LPS and recombi-
nant murine IFN-. As expected, bone marrow–derived
macrophages from MIIG  IL-4R/ mice did not pro-
duce more nitrite after recombinant murine IFN- treat-
ment compared with levels induced by LPS treatment
-/-
2 R3
104101100 102 103104
R4
104101100 102 103
Ce
ll n
u
m
be
r
Ce
ll n
u
m
be
r
cMyc
IL-4Rα-/-
MIIG X IL-4Rα-/-
104101100 102 103
Ce
ll n
u
m
be
r
104 104101100 102 103
Ce
ll n
u
m
be
r
cMyc
R2 R3 R4
Figure 1. Generation of mice with a macrophage-specific loss
of IFN- responsiveness and a global loss of IL-4/IL-13 respon-
siveness. A: Nitrite production from WT, IL-4R/, or MIIG 
IL-4R/ bone marrow–derived macrophages (BMDMs) that
were either left untreated (Med) or stimulated with Escherichia
coli LPS, 100 ng/mL, or a combination of LPS and IFN-, 20
ng/mL, for 24 hours. Data show the mean SE of triplicate wells.
The experiment was performed three times. **P  0.001. Flow
cytometric analysis of thioglycollate-elicited peritoneal exudate
cells from IL-4R/ or MIIG  IL-4R/ mice cell surface
expression of Myc (alias c-myc) on CD11b and F4/80 cell
populations (B) and CD11b and/or Ly6C/G cell populations
(C). This is representative of three independent mice analyzed
per group.-4Rα
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tometric analysis of thioglycollate-elicited peritoneal exu-
date cells from WT, IL-4R/, and MIIG  IL-4R/
mice confirmed that CD68-driven transgene expression
was primarily associated with CD11b F4/80 double-
positive cells, and not CD11b Ly6G/C cell populations
(Figure 1, B and C). Thus, MIIG  IL-4R/ mice are
incapable of IFN-–driven M1 cell activation and IL-4/IL-
13–driven AAM/M2 cell activation.
Acute Schistosomiasis in MIIG  IL-4R/
Mice Is Characterized by Severe Weight Loss,
Mortality, and Increased Liver
Immunopathological Characteristics
The absence of AAM/M2 cells during acute murine schis-
tosomiasis results in exacerbated tissue injury, cachexia,
and mortality.17 To determine whether M1 cells contribute
to this severe disease phenotype, WT, MIIG, IL-4R/,
and MIIG  IL-4R/ mice were percutaneously in-
fected with 50 to 60 S. mansoni cercariae and monitored
for changes in weight or survival. Although no obvious
differences in morbidity or mortality were observed be-
tween WT and MIIG mice, both IL-4R/ and MIIG 
IL-4R/ strains lost a significant amount of weight from
5 to 8 weeks after infection (Figure 2A). Unexpectedly,
cachexia was more severe in MIIG IL-4R/mice com-
pared with all other strains, and these animals experienced
90% mortality by 9 weeks after infection (Figure 2B).
The S. mansoni eggs continuously accumulate within
the liver during infection. Serum levels of AST and liver
granuloma sizes were determined to evaluate whether
weight loss was associated with an increase in hepatic
tissue injury and immunopathological characteristics, re-
spectively.15,17 As previously demonstrated, S. mansoni–
infected IL-4R/ mice produced higher levels of AST
than WT mice.17 However, infected MIIG  IL-4R/
mice produced even higher AST levels than IL-4R/
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were smaller than WT granulomas (Figure 3B). The ex-
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Figure 3. MIIG  IL-4R/ mice show greater liver injury and granulo-
matous pathological characteristics compared with IL-4R/ mice during
acute schistosomiasis. The S. mansoni–infected WT, IL-4R/, and MIIG 
IL-4R/ mice were evaluated at 7.5 weeks after infection for serum levels
of AST (A) and liver granuloma cross-sectional area (B). Data show the mean
SE (n  300 granulomas per group). C: Representative images of liver granulo-
mas after H&E staining of infected liver tissue at 7.5 weeks after infection.
Photomicrographs show representative liver sections from S. mansoni–inocu-
lated mice at 7.5 weeks after infection. Scale bar  100 m. Arrows, parasite6
reased
mice aova; arrowheads, areas of perivascular inflammation. *P 0.05, **P 0.01, and
***P  0.001.
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MIIG  IL-4R/ mice were associated with greater
perivascular inflammation within hepatic tissue of in-
fected MIIG  IL-4R/ mice compared with WT or
IL-4R/ strains (Figure 3C). We also noted that more
severe peritonitis developed in MIIG  IL-4R/ mice
compared with WT or IL-4R/ strains at 7.5 weeks after
infection (data not shown). These data suggest that a
combined lack of M1 and M2 cells within MIIG  IL-
4R/ mice resulted in greater liver inflammation during
S. mansoni infection.
Lack of IL-4 and IFN- Responsiveness in
Macrophages Does Not Alter the Production of
TH1, TH17, or Treg-Associated Cytokine
Production
Host survival during schistosomiasis is dependent on the
balanced production of pro- and anti-inflammatory cyto-
kines.18 Thus, we asked whether severe disease in MIIG 
IL-4R/mice was associated with dysregulated cytokine
production. Mesenteric lymph node cells from WT, IL-
4R/, and MIIG  IL-4R/ mice were isolated at 7
weeks after infection and analyzed for the production of
IFN-, IL-17A, IL-5, and IL-12p40 after restimulation with
SEA. Themesenteric lymph nodes from both IL-4R/ and
MIIG  IL-4R/ mice released significantly more IFN-
and IL-17A and significantly less IL-5 than WT MLNs after
SEA stimulation (Figure 4, A–C). However, there were only
moderate differences between the cytokine profiles of IL-
4R/ and MIIG  IL-4R/ mice. SEA-induced IL-
12p40 release was significantly lower from MIIG 
IL-4R/ MLNs compared with IL-4R/ mice, which
is consistent with evidence that IFN- promotes IL-12
responses (Figure 4, A–C).19
Redundant functions of IL-10 and TGF- suppress he-
patic immunopathological characteristics and promote
host survival during murine schistosomiasis.15 To deter-
mine whether MIIG  IL-4R/ mice failed to express
these cytokines, hepatic mRNA expression levels of IL-10
and TGF-1 were quantified in WT, IL-4R/, and MIIG 
IL-4R/ mice at 7 weeks after infection. Both IL-4R/
and MIIG  IL-4R/ mice expressed significantly higher
levels of these cytokine transcripts than infectedWTmice or
any of the uninfected mouse strains (Figure 4, D–F). How-
ever, MIIG  IL-4R/ mice did not generate markedly
different cytokine responses compared with the IL-4R/
strain, inasmuch as the production of TH1, TH17, TH2, and
Treg-associated cytokines were similarly produced.
MIIG  IL-4R–Deficient Mice Have a Specific
Defect in IDO Production that Is Required for
Protection against Excessive Tissue Injury
during Acute Schistosomiasis
Given that IDO is an IFN-–inducible enzyme that medi-
ates immunosuppression through tryptophan catabo-
lism,20,21 we next asked whether MIIG  IL-4R/ mice
were uniquely defective in the expression of this gene.IDO-1 mRNA levels were threefold to fourfold increased
within the liver and intestine of WT and IL-4R/ strains
versus naïve controls (Figure 5, A and B). However,
MIIG  IL-4R/ mice failed to increase IDO-1 mRNA
expression versus baseline levels in either of these af-
fected organs (Figure 5, A and B). Measurement of IDO-2
mRNA levels did not show increased expression during
S. mansoni infection in any of the three strains analyzed
(data not shown).
To determine whether IDO expression was functionally
important, S. mansoni–infected mice were administered
the specific IDO antagonist 1-MT in drinking water.16 The
administration of 1-MT to S. mansoni–infected WT and
IL-4R/ mice from 4 weeks after infection had moder-
ate effects on the former but severely affected the latter.
Indeed, 1-MT–treated IL-4R/ mice experienced rapid
weight loss (Figure 5C) and 50% mortality by 8 weeks
after infection (Figure 5D), which was a similar phenotype
to MIIG  IL-4R/ mice. The 1-MT treatment in IL-
4R/–deficient mice also led to a marked increase in
the AST (Figure 5E) and endotoxin (Figure 5F) levels in
serum, the latter of which indicated a loss of intestinal
mucosal barrier function.8,17 Conversely, 1-MT treatment
did not alter the AST or LPS levels within infected WT
mice (Figure 5, E and F). Overall, these data support a
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Figure 4. The S. mansoni–infected MIIG  IL-4R/ mice and IL-4R/
mice generate a similar cytokine response within lymphoid and hepatic
tissues during the acute infection phase. Supernatant levels of IFN- (A),
IL-17A (B), IL-5 (C), and IL-12p40 (D), produced from mesenteric lymph
node cells of S. mansoni–infected mice at 7 weeks after infection, that were
either left untreated (Med) or stimulated with 10 g/mL SEA, as determined
by ELISA. Data show the mean  SE of triplicate wells (n  4 mice per
group). The experiment was performed three times. Hepatic mRNA expres-
sion levels of IL-10 (E) and TGF-1 (F) were quantified in WT (circles),
IL-4R/ (squares), and MIIG  IL-4R/ (triangles) mice at 7 weeks
after infection. Open symbols, naïve; closed symbols, infected. The experi-
ment was performed three times. **P  0.01 as determined by one-way
analysis of variance.hypothesis that the effects of IFN- on macrophages are
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AJP May 2012, Vol. 180, No. 5beneficial for S. mansoni–infected hosts that lack IL-4R
expression.
Discussion
Macrophages are critical regulators of inflammation and
immunopathology during murine schistosomiasis. Al-
though IL-4/IL-13–dependent differentiation of AAM/M2
cells prevents TH1-associated lethality in this model, it
remained unclear whether the mechanism required the
suppression of M1 cell differentiation. In this study, we
compared mice that lacked AAM/M2 cells with animals
deficient in both AAM/M2 and M1 cells for differences in
host susceptibility after acute infection with S. mansoni.
Evidence shows that when the host is unable to generate
AAM/M2 cells, IFN-–dependent M1 cell development
actually suppresses hepatic inflammation and protects
against lethal disease. This host-protective effect of M1
cells is most likely due to IDO, an IFN-–inducible en-
zyme known for its highly immunosuppressive effects.
Thus, contrary to our initial hypothesis, our data suggest
that both M1 and AAM/M2 cells serve as regulators of
inflammation and immunosuppression during murine
schistosomiasis.
Survival during murine schistosomiasis is dependent
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E Fon the balance between pro- and anti-inflammatory cyto-kine production.15,22 Although mice unable to mount an
IL-4–driven AAM/M2 response develop severe liver and
intestinal injury within 7 to 8 weeks after infection, the
overproduction of type 2 cytokines leads to excessive
fibrosis and mortality beyond 20 weeks.11,23 Furthermore,
the lack of sufficient IL-10 and TGF- causes a predom-
inant IFN- and IL-17 response that results in rapid death
of infected hosts shortly after the onset of worm ova
production.15 Given that the effects of IFN- on macro-
phages have profound effects on cytokine production, it
was somewhat unexpected that antigen-induced IFN-
and IL-17A production was not significantly different be-
tween IL-4R/ and MIIG  IL-4R / mice. However,
the increased production of these cytokines in these
strains, compared with WT, is consistent with prior re-
ports that evidence that AAM/M2-specific genes sup-
press IFN- and IL-17A during acute schistosomiasis.
Interestingly, IL-4R/ and MIIG  IL-4R/ ex-
pressed higher levels of IL-10 and TGF-, compared with
WT, which made it unlikely that defective production of
these anti-inflammatory cytokines could explain why
MIIG  IL-4R/ mice experienced greater disease
susceptibility compared with WT and IL-4R/ mice.
In most immunocompetent mouse strains, a fibrotic
granulomatous reaction develops around each worm
e IDO
α-/- MIIG X IL-4Rα-/-
8 9 10
post-infection
**
*
IL-4Rα-/-
Figure 5. The S. mansoni–infected MIIG  IL-
4R/mice fail to up-regulate IDO, which pro-
tects IL-4R/ mice against lethal multiorgan
inflammation during acute schistosomiasis. Liver
(A) and intestinal (B) mRNA expression levels
for IDO at 7.5 weeks after infection. Data show
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IL-4R
7
eeks ova; however, granulomas in IL-4R/ mice are signifi-
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AJP May 2012, Vol. 180, No. 5cantly smaller. AAM/M2 cells are not required for liver
granuloma development or fibrosis, yet the lack of
AAM/M2 results in significantly greater hepatocellular in-
jury.17 Although we expected that an increase of M1-
associated inflammation was the culprit of exacerbated
liver damage in mice lacking AAM/M2 cells, surprisingly,
MIIG  IL-4R/ mice experienced greater hepatic in-
jury than IL-4R/ mice. Furthermore, the liver granulo-
mas in MIIG  IL-4R/ mice were larger compared
with IL-4R/ mice. Notably, there was greater perivas-
cular inflammation in MIIG  IL-4R/ mice that did not
appear to localize around worm ova, a finding that was
much less evident in IL-4R/ and nearly absent in WT
liver tissue. Given that hepatocellular injury was greater in
S. mansoni–infected MIIG  IL-4R/ mice compared
with the other strains, these data implied the loss of
important counterregulatory mechanisms that were en-
gaged in both WT and IL-4R/ strains.
Demonstration that MIIG  IL-4R/ mice fail to up-
regulate IDO expression within liver and intestine pro-
vided critical insight to understanding how IFN-–depen-
dent effects on macrophages promoted host protection.
The 5= flanking region of the IDO gene contains IFN-
stimulated response elements and IFN-–activated site
sequences, which drives IDO expression within hemato-
poietic and nonhematopoietic cell lineages.24,25 IDO is
the rate-limiting enzyme for the catabolism of tryptophan,
which is an essential amino acid required for cell prolif-
eration. IDO production from myeloid antigen-presenting
cells causes cell cycle arrest in lymphocytes.21,26 IDO
expression within macrophages and dendritic cells is a
particularly important mechanism that limits inflammation
within the gastrointestinal tract and the tumor cell mi-
croenvironment.27 Lack of IDO production from MIIG 
IL-4R/ mice during acute schistosomiasis suggested
that defective IDO production from macrophages re-
sulted in the greater accumulation of inflammatory cells
and excessive collateral damage to parasitized or-
gans. Consistent with this hypothesis, IDO neutraliza-
tion in IL-4R/ mice significantly increased damage
to the liver and intestine compared with mock-treated
IL-4R/ mice.
WT C57BL/6 mice expressed IDO within the liver and
intestine at levels equivalent to IL-4R/ mice, which
was somewhat unexpected because of the low levels of
IFN- production after infection. Although 1-MT treatment
in WT mice did not significantly change disease outcome,
the levels of IFN- produced from MLN cultures were
higher compared with mock-treated WT mice (data not
shown). However, 1-MT treatment of infected IL-4R/
mice caused a dramatic increase in morbidity andmortality.
Overall, these data suggest that, although IDO production
in WT mice is important in limiting the production of type 1
cytokines, this function is not critical for host survival. How-
ever, in the absence of a strong TH2 response that pro-
motes AAM/M2 cell activation, IFN-–mediated IDO from
macrophages provides a critical secondary mecha-
nism that limits overexuberant inflammation and immu-
nopathology.28 This scenario bears potential relevance
to schistosomiasis in humans because certain IFN-
polymorphisms are associated with reduced periportalfibrosis and reduced liver immunopathological charac-
teristics.29
In conclusion, during murine schistosomiasis, the ab-
sence of IL-4/IL-13–dependent AAM/M2 cells, combined
with the additional loss of IFN-–driven M1 cells, results
in significantly worse disease than the sole loss of
AAM/M2 cells alone. The underlying mechanism is likely
IFN-–dependent IDO production from macrophages,
which limits the intensity of inflammation directed against
worm ova and, therefore, protects the infected host
against excess collateral damage to parasitized organs.
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